James Stevermer News Today

This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef

The U.S. Preventive Services Task Force proposed new recommendations to help prevent falls in older adults. =

This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef

This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for hypertensive disorders in pregnant persons with blood pre

The U.S. Preventive Services Task Force released a recommendation this week calling on health care providers to prescribe all approved PrEP options for people at increased risk for HIV.

The new statement gave ‘A’ grades to all 3 FDA-approved PrEP drugs: Truvada, Descovy, and an injectable called Apretude.

Two new antiretrovirals have been approved by the US Food and Drug Administration since the US Preventive Services Task Forces last report, which now includes new options.

Preexposure prophylaxis should be prescribed to individuals at risk of acquiring HIV to prevent HIV, according to the USPSTF.

TUESDAY, Aug. 22, 2023 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends prescription of preexposure prophylaxis (PrEP) with effective antiretroviral therapy for individuals at increased risk for HIV acquisition. This recommendation forms the basis of a final recommendation statement published in the Aug. 22/29 issue of the Journal of the American Medical